news Archives - rfxcel.com
Rfxcel Logo

Category: news

From Traceability Regulations Compliance to a Customized Service

Posted on by rfxadmin

Collaboration between Ferring Pharmaceuticals and Antares Vision Group continues with a new testing and validation software and a better supply of spare parts.

Travagliato (Brescia), September 13, 2023. The collaboration, born in 2015, between Ferring Pharmaceuticals, a leader in reproductive medicine, maternal health, and specialist areas within gastroenterology and urology, and Antares Vision Group, a technological partner in digitalization of products and supply chains for companies and institutions, and a leader in traceability and inspection for quality control, continues. After an initial approach following the entry into force of the serialization regulations, Ferring Group currently uses Antares Vision Group solutions on 23 lines in plants in Switzerland, the United States, China, the Czech Republic, Israel, Scotland and Indonesia.

Thanks to the collaboration with Antares Vision Group, Ferring Group has significantly reduced procurement times for spare parts with integrated supply chain processes that always ensure the availability of the minimum quantity in stock, increasing the efficiency of maintenance operations. For spare parts, it is a reduction of over 90% in procurement times.

“This is one of the main benefits originating from the collaboration with Antares Vision Group started in 2015,” states Fernando Monteiro, Global OT Applications Senior Manager at Ferring Pharmaceuticals Group. “We went through challenging times in a growing serialization world. Regulations have been evolving over the years, impacting our production planning, sometimes making it more complex.”

Ferring Pharmaceuticals and Antares Vision Group have jointly developed customized solutions to improve maintenance operations. In particular, since many Ferring sites use the same components — which is convenient considering that having different spare parts at each site would be extremely costly — and a shortage of stocks would jeopardize business continuity, Antares Vision Group and Ferring have put in place a list of spare parts capable of covering the needs of the various plants involved. These components are in stock at the Antares Vision Group headquarters in Italy, available to be shipped worldwide at any time.

Due to the robust international agreement and exceptional collaboration between the two firms, Ferring Pharmaceuticals has seamlessly met specific requests, consistently ensuring adherence to the regulatory standards of every country they serve.

Furthermore, Ferring Pharmaceuticals has increased the level of efficiency of the production process during ordinary maintenance operations, not only by increasing the availability of spare parts, but also by adopting new solution for testing and qualifications to maintain operational continuity at the highest levels also in case of new releases and software updates.

To facilitate testing and qualification, a solution was developed that combines both hardware and software and replicates the functionality of Ferring’s production lines. This system can simulate operations in non-production settings such as offices and labs, making validation more accessible. Operating offline and without real packaging material, it enables comprehensive testing without disrupting actual production timelines.

“Our collaboration with Ferring Pharmaceuticals has evolved since the beginning following the needs and requirements of the customer,” concludes Mattia Assanelli, Service Director of Antares Vision Group. “By paying attention to regulatory developments and deepening the knowledge of the processes of the different Ferring sites, we have been able to improve production and maintenance efficiency, with a drastic reduction in spare parts procurement times and with a system that tests software updates, excluding the risk of line downtime.”

 

About Antares Vision Group
Antares Vision Group is driving digitalization of products and supply chains by leading traceability, inspection, and integrated data management. AV Group helps companies and institutions to achieve safety, quality, efficiency, and sustainability, enabling Trustparency®.

DIAMIND, AV Group’s integrated ecosystem of solutions, simplifies the technology environment and supports businesses growth by enabling a data-driven and tailored journey to digital innovation. Connecting physical products with digital identities, DIAMIND runs at the line, factory, warehouse, enterprise, and supply chain levels, and guarantees product quality (inspection systems and equipment) and end-to-end traceability (from raw materials to production, from distribution to the consumer and back) through integrated data management, applying artificial intelligence and potentially blockchain.

AV Group operates in the Life Science (pharmaceuticals, medical devices, and hospitals), Beverage, Food, Cosmetics, Chemicals, and Packaging industries and potentially many others.

AV Group has been listed in STAR segment of Euronext since 14 May 2021 and has been included in the Euronext Tech Leaders index, dedicated to leading tech companies with high growth potential, since July 2022.

In 2022, Antares Vision Group recorded a turnover of €223 million. The Group operates in 60 countries, employs more than 1,100 people, and has a consolidated network of over 40 international partners. www.antaresvisiongroup.com

About Ferring Pharmaceuticals
Ferring Pharmaceuticals is a research-driven, specialty biopharmaceutical group committed to helping people around the world build families and live better lives. Headquartered in Saint-Prex, Switzerland, Ferring is a leader in reproductive medicine and maternal health, and in specialty areas within gastroenterology and urology. Ferring has been developing treatments for mothers and babies for over 50 years and has a portfolio covering treatments from conception to birth. Founded in 1950, privately-owned Ferring employs over 7,000 people worldwide. The company has operating subsidiaries in more than 50 countries and markets its products in over 100 countries.

Contacts for more information:

Raffaella Mora | PR Specialist Antares Vision Group
raffaella.mora@partner.antaresvision.com
+39 349 0709470

Press Office
Soluzione Group S.R.L. – Via F. Lana, 1 – 25020 Flero (BS) – Italy
T: +39 030 3539159
Giusy Martin | Cell. +39 3881681168
martin@soluzionegroup.com

Antares Vision S.p.A.
Via del Ferro, 16 – 25039 Travagliato (BS) – Italy
T: +39 030 7283500
info@antaresvision.com – www.antaresvisiongroup.com

Antares Vision Group, Through rfxcel Technology, Becomes the First DSCSA Solution Provider to Join NABP’s Pulse Interoperable Partner Program

Posted on by rfxadmin

A pharmacist in a white lab coat scanning a box of prescription medicine

AV Group, which has a long history of working with the National Association of Boards of Pharmacy, extends its commitment to DSCSA compliance by joining the Partner Program.

Travagliato (Brescia), August 29, 2023. Antares Vision Group, an Italian multinational and a leading provider of track and trace and quality control systems, today announced that it has partnered with the National Association of Boards of Pharmacy® (NABP®) through the Pulse Interoperable Partner program. This new initiative aims to accelerate interoperability in the drug supply chain by providing a framework for solution providers to integrate directly with Pulse by NABP™, an inclusive, accessible, and secure digital platform that simplifies the process of achieving Drug Supply Chain Security Act (DSCSA) compliance.

Nearly 10 years ago, the DSCSA was enacted to ensure the safety of the U.S. pharmaceutical supply chain. The law, which has a deadline of November 2023, requires cooperation and interoperability among a wide range of industry stakeholders and solution providers. As the deadline approaches, these actors must continue to work together to ensure they will meet the complex requirements of the DSCSA.

NABP has been and will continue to be a key stakeholder in the DSCSA effort, representing the needs and interests of state regulators. This includes Pulse by NABP, which facilitates DSCSA compliance across the supply chain by providing additional functionality and data required to ensure seamless interoperability among participants. Antares Vision Group, through rfxcel technology, recognizes the importance of NABP’s contributions and is proud to be the first solution provider to sign up for this partner program.

“We have been working with the NABP for years and have watched their continued commitment to the DSCSA effort,” said rfxcel Senior Vice President of Product and Strategy Herb Wong. “Their involvement offers critical insight into the needs of the state boards of pharmacy and the small dispenser community and reflects the feedback that we’ve been hearing from our customers. We are excited to participate in the Pulse Interoperable Partner Program to ensure safe pharmaceuticals for patients and consumers.”

”Antares Vision Group became the first solution provider to be a Pulse Interoperable Partner, signing on within hours of the program being announced at  NABP’s recent Interoperability Summit,” said NABP Executive Director/Secretary Lemrey “Al” Carter, PharmD, MS, RPh. “They have been an ardent supporter of Pulse and we’re delighted to continue the collaboration to secure the prescription drug supply chain and protect public health.”

For more information, contact Herb Wong, senior vice president of product and strategy, at hwong@rfxcel.com.

About Antares Vision Group

Antares Vision Group is driving digitalization of products and supply chains by leading traceability, inspection, and integrated data management. AV Group helps companies and institutions to achieve safety, quality, efficiency, and sustainability, enabling Trustparency®.

DIAMIND, AV Group’s integrated ecosystem of solutions, simplifies the technology environment and supports businesses’ growth by enabling a data-driven and tailored journey to digital innovation. Connecting physical products with digital identities, DIAMIND runs at the line, factory, warehouse, enterprise, and supply chain levels, and helps guarantee product quality (inspection systems and equipment) and end-to-end traceability (from raw materials to production, from distribution to the consumer and back) through integrated data management.

AV Group operates in the life science (pharmaceuticals, medical devices, and hospitals), beverage, food, cosmetics, chemicals, and packaging industries and potentially many others.

AV Group has been listed in STAR segment of Euronext since May 2021 and has been included in the Euronext Tech Leaders index, dedicated to leading tech companies with high growth potential, since July 2022.

In 2022, Antares Vision Group recorded a turnover of €223 million. The Group operates in 60 countries, employs more than 1,300 people, and has a consolidated network of over 40 international partners. To learn more, please visit antaresvisiongroup.com and rfxcel.com.

Antares Vision Group, Through rfxcel Technology, Joins the Gateway Certified™ Program to Lead Verification Router Service (VRS) Standardized Testing Initiative

Posted on by rfxadmin

 

Serialized boxes of medicine on a manufacturing line in a pharmaceutical production facility

AV Group, which led an FDA-approved pilot to extend testing of the VRS, continues its industry leadership by helping to test industry readiness ahead of this year’s DSCSA deadline.

Travagliato (Brescia), August 22, 2023. Antares Vision Group, an Italian multinational and a leading provider of track and trace and quality control systems, today announced that it has joined the Gateway Certified™ program for Verification Router Service (VRS) verification to help pharmaceutical stakeholders prepare for upcoming serialization and drug product verification requirements in the U.S. Drug Supply Chain Security Act (DSCSA).

The industry established the VRS specifications to help verify the authenticity of products for salable returns. Many providers have developed solutions based on the VRS specification and have voluntarily collaborated in testing to ensure compliance and interoperability.

The Gateway Certified™ program for VRS Verify was established in response to industry concerns that manual methods and self-testing among more than a dozen solution providers was time-consuming, was not scalable, and lacked independent oversight.

Recognizing the importance of connectivity and interoperability, Antares Vision Group, through rfxcel technology, is committed to independent and objective VRS verification testing. “We recognize that solution providers need a more scalable, repeatable, and open testing approach,” said rfxcel CEO Glenn Abood. “We see the limitations of the current approach and see the potential impact on robust, reliable systems as well as adaptation to emerging requirements.”

“We appreciate Antares Vision Group’s leadership and ongoing commitment to facilitate information interoperability and product verification in the pharmaceutical supply chain,” said Gary Lerner, President of Gateway Checker Corporation. “We encourage all solution providers interested in establishing demonstrable VRS conformance to join the Gateway Certified™ program.”

The Gateway Certified™ program provides independent, objective, automated use-case testing to assure that pharmaceutical drug product verification requests and responses consistently meet industry and FDA regulatory requirements. It examines a system’s conformance to requirements and provides objective evidence that it consistently meets industry and regulatory needs.

Herb Wong, rfxcel senior vice president of product and strategy, will be facilitating a Roundtable Discussion about the VRS at the Healthcare Distribution Alliance (HDA) 2023 Traceability Seminar in Washington, D.C. To learn more, click the image below and visit Antares Vision Group at Table-Top 21 at the seminar.

Picture of Antares Vision Group's HDA Traceability Seminar information page and sign-up form

About Antares Vision Group

Antares Vision Group is driving digitalization of products and supply chains by leading traceability, inspection, and integrated data management. AV Group helps companies and institutions to achieve safety, quality, efficiency, and sustainability, enabling Trustparency®.

DIAMIND, AV Group’s integrated ecosystem of solutions, simplifies the technology environment and supports businesses’ growth by enabling a data-driven and tailored journey to digital innovation. Connecting physical products with digital identities, DIAMIND runs at the line, factory, warehouse, enterprise, and supply chain levels, and helps guarantee product quality (inspection systems and equipment) and end-to-end traceability (from raw materials to production, from distribution to the consumer and back) through integrated data management.

AV Group operates in the life science (pharmaceuticals, medical devices, and hospitals), beverage, food, cosmetics, chemicals, and packaging industries and potentially many others.

AV Group has been listed in STAR segment of Euronext since May 2021 and has been included in the Euronext Tech Leaders index, dedicated to leading tech companies with high growth potential, since July 2022.

In 2022, Antares Vision Group recorded a turnover of €223 million. The Group operates in 60 countries, employs more than 1,300 people, and has a consolidated network of over 40 international partners. To learn more, please visit antaresvisiongroup.com and rfxcel.com.

For further information, contact Herb Wong, senior vice president of product and strategy, at hwong@rfxcel.com.

About Gateway Checker Corporation

Gateway Checker™ provides a software as a service platform to facilitate product traceability, DSCSA compliance, and unambiguously verify the interoperability readiness of serialized pharmaceutical transaction records. Drug manufacturers, repackagers, wholesalers, and distributors can quickly and continuously test, validate, and certify adherence to GS1 US Rx EPCIS and VRS product verification application standards.

Gateway Checker is the GS1 US Rx Certified Conformance Testing Service, and is owned and operated by the Gateway Checker Corporation, a wholly owned subsidiary of BrandSure, LLC.

For more information about the Gateway Certified™ program, including VRS System Validation, contact Eran Strod at certified@gatewaychecker.com.

Antares Vision Group Attains ISO/IEC 27001 Cybersecurity Certification for Serialization and Global Regulatory Compliance

Posted on by rfxadmin

Obtained through rfxcel, the information security management systems certification demonstrates the Group’s ability to protect and manage customers’ data on a global scale, complementing rfxcel’s ISO 9001 certification.

Travagliato (Brescia), July 11, 2023. Antares Vision Group (EXM, AV:IM), a leading provider of track and trace and quality control systems, through rfxcel’s San Ramon location, has attained ISO/IEC 27001 certification for information security management systems (ISMS), an important and significant achievement in the supply chain software solutions industry.

The certification demonstrates rfxcel’s incorporation of best-in-class technologies and best practices to preserve the confidentiality, integrity, and availability of customer data while proactively managing risks. As customers globally share serialization and other supply chain data, their needs for security, system controls, and governance grows. rfxcel’s  continuous advancements within its controls and technology help customers comply with international security standards and regulations.

rfxcel Vice President of Global Quality Management Amit Sewak said the certification is a clear statement. “It means we are committed to protecting our clients from global security threats. We have an incredible organization that is focused on developing and delivering secure solutions that focus on our customers’ needs and the complex regulatory landscape they function within.”

Sewak added that the ISO/IEC 27001 certification confirms that the structure of rfxcel’s Quality Management System and ISMS exemplifies compliance internationally. “Regardless of the regulatory standards that clients function within, rfxcel is prepared today and for the future,” he said.

Glenn Abood, CEO of rfxcel, said the certification should give customers peace of mind about working with Antares Vision Group. “We have strategies to manage the performance, quality, and effectiveness of our products and services,” he explained. “Our customers have the assurance that their data is strictly controlled, stored, and protected.”

In addition to the ISO/IEC 27001 certification, rfxcel’s existing ISO 9001 certification conveys its commitment to customers and continual improvement. “Our customers know our management systems and architecture are efficient. They know we perform at a high level and use leading technologies to support them,” Sewak said.

For more information, contact rfxcel Senior Communications and Content Manager Garrison Spik at garrison@rfxcel.com.

About Antares Vision Group

Antares Vision Group is driving digitalization of products and supply chains by leading traceability, inspection, and integrated data management. AV Group helps companies and institutions to achieve safety, quality, efficiency, and sustainability, enabling Trustparency™. DIAMIND, AV Group’s integrated ecosystem of solutions, simplifies the technology environment and supports businesses growth by enabling a data-driven and tailored journey to digital innovation. Connecting physical products with digital identities, DIAMIND runs at the line, factory, warehouse, enterprise, and supply chain levels, and guarantees product quality (inspection systems and equipment) and end-to-end traceability (from raw materials to production, from distribution to the consumer and back) through integrated data management, applying artificial intelligence and potentially blockchain. AV Group operates in the Life Science (pharmaceuticals, medical devices, and hospitals), Beverage, Food, Cosmetics, Chemicals, and Packaging industries and potentially many others. AV Group has been listed in STAR segment of Euronext since 14 May 2021 and has been included in the Euronext Tech Leaders index, dedicated to leading tech companies with high growth potential, since July 2022. In 2022, Antares Vision Group recorded a turnover of €223 million. The Group operates in 60 countries, employs more than 1,100 people, and has a consolidated network of over 40 international partners. For further information, visit www.antaresvisiongroup.com.

Antares Vision Group Becomes the First DSCSA Compliance Software Awarded a Spot on the GSA MAS Contract with Lovell Government Services

Posted on by rfxadmin

Antares Vision Group Becomes the First DSCSA Compliance Software Awarded a Spot on the GSA MAS Contract with Lovell Government Services

The distinction is a result of a partnership between AV Group subsidiary rfxcel and service-disabled veteran-owned small business (SDVOSB) Lovell Government Services that aims to protect patients served by government entities.

Travagliato (Brescia), June 28, 2023. Antares Vision Group, through rfxcel, a leading provider of supply chain traceability and compliance solutions, has been awarded a spot on the General Services Administration (GSA) Multiple Award Schedule (MAS) contract. With partner Lovell Government Services, a service-disabled veteran-owned small business (SDVOSB), this significant achievement demonstrates the companies’ commitment to federal and state government entities that operate pharmacies and the patients they serve.

Through its partnership with Lovell, rfxcel is the first Drug Supply Chain Security Act (DSCSA) compliance software provider to be awarded a spot on the GSA MAS contract, a procurement vehicle for government agencies to purchase goods and services from pre-approved vendors. The contract includes pre-negotiated terms and conditions that simplify the procurement process.

The DSCSA is designed to improve the safety and security of the drug supply chain in the United States by rapidly detecting and removing harmful drugs. It requires manufacturers, distributors, dispensers (i.e., pharmacies and health systems), and other entities to track, trace, and verify certain medicines as they are received and dispensed.

rfxcel’s DSCSA solution for government dispensers is already in use by the Ohio Department of Veterans Affairs. Lovell is a contracted vendor for many government agencies, including the Department of Veterans Affairs, the Defense Logistics Agency, and the Department of Defense.

“Listing on the GSA MAS contract through Lovell is a win-win for everyone,” said rfxcel Vice President of Government Services Greg Moulthrop. “First, it protects patients who use government pharmacies. But it also enables government agencies to easily and efficiently purchase our DSCSA compliance software solutions and gives government customers the dual benefit of complying with the DSCSA while working toward their SDVOSB procurement goals.”

“We are excited to be partnering with Antares Vision Group, through rfxcel, on this important initiative,” said Chris Lovell, CEO of Lovell Government Services. “rfxcel has made it their mission to help federal pharmacies meet DSCSA compliance requirements by November 2023 and Lovell is honored to play a part in it. DSCSA isn’t just about protecting the supply chain, it is also about protecting patients.”

For more information, contact rfxcel Senior Government Affairs Advisor Kevin Smith at ksmith@rfxcel.com or 563-590-9408.

About Antares Vision Group & rfxcel

Antares Vision Group, through rfxcel, is a leading provider of supply chain traceability and compliance solutions. The company’s mission is to deliver value to its customers through a comprehensive suite of software solutions that ensure supply chain integrity, visibility, and regulatory compliance. rfxcel’s solutions have been used by leading companies in industries such as pharmaceuticals, food and beverage, and consumer goods. Learn more here.

About Lovell Government Services

Lovell Government Services is a trusted government vendor since 2013 with a proven track record of success. Lovell is a two-time Inc. 5000 honoree and leader in the federal space. They partner with medical and pharmaceutical companies looking to better serve veteran and military patient populations, increase their federal revenue stream, and win government contracts. Click here to learn more.

Antares Vision Group & Result Group Digitalize Millions of Unique Game Pieces for Enhanced Consumer Engagement and Traceability Across Australia

Posted on by rfxadmin

Antares Vision Group & Result Group Digitalize Millions of Unique Game Pieces for Enhanced Consumer Engagement and Traceability Across Australia

The partners are deploying AV Group’s DIAMIND solution to manage fast food leader Hungry Jack’s UNO™ campaign, one of the most advanced intelligent packaging initiatives in the Australian market.

Travagliato (Brescia), June 14, 2023 – Antares Vision Group, the technology partner for digitalization of products and supply chains and a leading provider of traceability and inspection  systems, has partnered with Result Group to manage Hungry Jack’s UNO™ campaign in Australia. Utilizing AV Group’s DIAMIND solution, they are managing millions of game pieces with unique digital identities and enhancing consumer engagement with the popular game.

Founded in 1971, Hungry Jack’s is the master Australian franchise of the Burger King Corporation and one of the country’s largest fast food chains, with more than 440 restaurants. It has over 19,000 employees and serves 1.7 million people every week. Its successful UNO™ campaign began in 2021 and is now in its third iteration.

This is Antares Vision Group’s first collaboration with Melbourne-based Result Group, which supplies innovative equipment and materials that help Australian businesses improve efficiency in their manufacturing and distribution processes. Result Group has manufactured the game pieces for every Hungry Jack’s UNO™ campaign.

AV Group’s DIAMIND solution generates and manages the unique digital identity for every game piece. It integrates with the digital printing of these “micro labels” and their application on food packaging, then commissions each to confirm its validity. When a customer redeems a game piece through Hungry Jack’s app, website, or in-store at the point of sale, DIAMIND confirms that it is legitimate, decommissions the digital ID, and integrates with prize fulfillment systems to complete the customer experience.

Result Group produces the game pieces, which look and feel like actual UNO™ cards, with conventional flexographic and digital printing presses plus a specialized converting system to bring the pieces together. The latter uses digital technology that enables mass customization, such as altering text and graphics without stopping or slowing down the printing process.

Simon Jones, Antares Vision Group’s Business Development Director, said, “Making Hungry Jack’s UNO™ campaign a success is a triumph of interoperability, integrating all the back-end systems, the front-end applications, and providing secure data management for every game piece and redemption event. But beyond the technology, it was about people and partnership, with the Result Group and AV Group teams working tightly with Hungry Jack’s and its service providers to really deliver on this.”

“What our partnership is doing for Hungry Jack’s is a great showcase for interoperability and showing the world about getting platforms to talk and share information with each other,” said Michael Doss or, Group General Manager at Result Group. “It’s paramount to the whole traceability story. Every one of those 17 million UNO™ game pieces is being tracked individually right through the supply chain. AV Group’s DIAMIND Enterprise solution is enabling expanded possibilities, enhanced interaction with customers through interoperability, and has improved the game overall.”

 

ABOUT ANTARES VISION GROUP

Antares Vision Group is driving digitalization of products and supply chains by leading traceability, inspection, and integrated data management. AV Group helps companies and institutions to achieve safety, quality, efficiency, and sustainability, enabling Trustparency™. DIAMIND, AV Group’s integrated ecosystem of solutions, simplifies the technology environment and supports businesses growth by enabling a data-driven and tailored journey to digital innovation. Connecting physical products with digital identities, DIAMIND runs at the line, factory, warehouse, enterprise, and supply chain levels, and guarantees product quality (inspection systems and equipment) and end-to-end traceability (from raw materials to production, from distribution to the consumer and back) through integrated data management, applying artificial intelligence and potentially blockchain. AV Group operates in the Life Science (pharmaceuticals, medical devices, and hospitals), Beverage, Food, Cosmetics, Chemicals, and Packaging industries and potentially many others. AV Group has been listed in STAR segment of Euronext since 14 May 2021 and has been included in the Euronext Tech Leaders index, dedicated to leading tech companies with high growth potential, since July 2022. In 2022, Antares Vision Group recorded a turnover of €223 million. The Group operates in 60 countries, employs more than 1,100 people, and has a consolidated network of over 40 international partners. For further information, visit www.antaresvisiongroup.com.  

 

For further information:

Raffaella Mora | PR Specialist Antares Vision Group: raffaella.mora@partner.antaresvision.com

Garrison Spik | Senior Communications & Content Manager, Antares Vision Group Supply Chain Visibility: garrison@rfxcel.com

 

Antares Vision Group Acquires SmartPoint Technologies

Posted on by rfxadmin

Travagliato (Brescia), May 2, 2023 – Antares Vision Group (EXM, AV:IM), a leading provider of track and trace and quality control systems, has acquired through its subsidiary rfxcel 100 percent of SmartPoint Technologies Ltd (SmartPoint), an Indian software product development company that builds powerful and intuitive software solutions.

SmartPoint, founded in 2010 by three entrepreneurs and headquartered in Chennai, offers diverse services and solutions to clients in more than 30 countries. It helps its customers to enhance their business prospects through software enhancement and development options in the IT arena. In Fiscal Year 2022–23 (year end March), Smart Point had 124 employees in India and Germany, and revenues of approximately €3.9 million, of which about 90 percent were generated with rfxcel.

“We have been working with SmartPoint for many years,” said rfxcel CEO Glenn Abood. “With this acquisition, we are internalizing very skilled and talented people, with exceptional expertise and specific abilities that match our interests. SmartPoint’s software development team has been working together for a long time and their know-how is a valuable asset for Antares Vision Group as we continue to invest in technological development to support our growth and to drive the innovation and digitalization process of supply chains.”

Strategic rationale

      • SmartPoint has proven expertise in pharmaceutical track and trace business verticals, and its software developments are directly implemented within the IT systems of top pharmaceutical companies that are rfxcel customers.
      • Its software development team will support rfxcel’s robust future growth.
      • The acquisition is an opportunity for rfxcel to prioritize software initiatives.
      • SmartPoint has approximately 20 full-time staff whose capabilities could be useful to other AV Group subsidiaries.
      • Having stronger in-house capacity will allow rfxcel to better negotiate with other software development companies for any excess work.
      • The deal prevents rfxcel’s competitors from acquiring the company and its know-how.

AV Group was assisted in the acquisition by Gandhi & Associates as legal consultants and Prakash Kotak for financial due diligence.

For more information, contact rfxcel Senior Communications and Content Manager Garrison Spik at garrison@rfxcel.com.

ABOUT ANTARES VISION GROUP
Antares Vision Group is an outstanding technology partner in digitalization and innovation for companies and institutions, guaranteeing the safety of products and people, business competitiveness and environmental protection. The Group provides a unique and comprehensive ecosystem of technologies to guarantee product quality (inspection systems and equipment) and end-to-end product traceability (from raw materials to production, from distribution to the consumer) through integrated data management, applying artificial intelligence and blockchain technology. Antares Vision Group is active in life science (pharmaceutical, biomedical devices and hospitals) and Fast-Moving Consumer Goods (FMCG), including food, beverage, cosmetics, and glass and metal containers. As a world leader in track and trace solutions for pharmaceutical products, the Group provides major global manufacturers (over 50% of the top 20 multinationals) and numerous government authorities with solutions, monitoring their supply chains and validating product authenticity. Listed since April 2019 on the Italian Stock Exchange in the Alternative Investment Market (AIM) segment and from 14 May 2021 in the STAR segment of Euronext; furthermore, from July 2022 included in the Euronext Tech Leaders index, dedicated to leading tech companies with high growth potential. In 2022, Antares Vision Group recorded a turnover of €223 million, operates in 60 countries, employs more than 1.180 people, and has a consolidated network of over 40 international partners. To learn more, please visit www.antaresvisiongroup.com.

Spherity and Antares Vision Group further partnership to ensure life sciences customers will comply with upcoming DSCSA regulations

Posted on by rfxadmin

Antares Vision Group, through rfxcel technology, has integrated Spherity’s Credentialing Service into its DSCSA solutions to verify authorized trading partners’ identities and licensing in all regulated interactions.

Reno, Nevada, April 25, 2023 — Spherity, a German leading provider of digital wallet and credentialing solutions, and Antares Vision Group, an Italian multinational and a leading provider of track and trace and quality control systems, are continuing a partnership that helps ensure life sciences customers comply with this year’s U.S. Drug Supply Chain Security Act (DSCSA) regulations.

By November 27, 2023, manufacturers, distributors, dispensers, and other actors in the life sciences supply chain must prove that they are legitimate organizations, or authorized trading partners (ATPs), as defined by the DSCSA.

The two companies first partnered in 2021, when Spherity’s Credentialing Solution, CARO, was integrated into the Group’s Verification Router Service (VRS) solution, enabled by rfxcel technologies, to allow life science customers to confirm their ATPs status. The combined solution also allows customers to exchange DSCSA-compliant electronic Product Identifier (PI) messages, trace products, and create an audit trail of their VRS business interactions.

CARO uses Self-Sovereign Identity (SSI) technology to establish a secure, verifiable digital enterprise identity for every ATP. By integrating the service into its VRS solution, rfxcel customers can ensure secure, authenticated data exchange with other ATPs and verify they have the credentials required by the DSCSA, including state licenses and U.S. Food and Drug Administration Entity Identifiers (FEIs).

“We partnered with Spherity to enable our customers to comply with this year’s DSCSA authorized trading partner (ATP) requirements,” said rfxcel Senior Vice President of Product and Strategy Herb Wong. “With Spherity’s CARO, our VRS solution automatically confirms whether a company is an ATP. Now, every customer can add ATP credentialing to our entire product portfolio and secure their VRS interactions.”

“Spherity will ensure that Antares Vision Group’s customers can securely exchange data with previously unknown entities,” said Georg Jürgens, Spherity’s Manager for Industry Solutions. “The concept of exchanging and verifying credentials using Digital Wallets supports company and product compliance use cases that require communication between regulators, existing supply chain partners, and new trading partners.”

Spherity and Antares Vision Group are members of the Open Credentialing Initiative (OCI), and both contribute to the standardization and industry-wide interoperability of credentialing technology.

For more information about the Spherity-Antares Vision Group partnership, their solutions for DSCSA compliance with ATP requirements, and the Open Credentialing Initiative, contact Spherity’s Manager for Industry Solutions Georg Jürgens at georg.juergens@spherity.com and visit caro.vc, and rfxcel Senior Vice President of Product and Strategy Herb Wong at hwong@rfxcel.com.

ABOUT ANTARES VISION GROUP

Antares Vision Group is an outstanding technology partner in digitalization and innovation for companies and institutions, guaranteeing the safety of products and people, business competitiveness, and environmental protection. The Group provides a unique and comprehensive ecosystem of technologies to guarantee product quality (inspection systems and equipment) and end-to-end product traceability (from raw materials to production, from distribution to the consumer) through integrated data management, applying artificial intelligence and blockchain technology. Antares Vision Group is active in life science (pharmaceutical, biomedical devices and hospitals) and Fast-Moving Consumer Goods (FMCG), including food, beverage, cosmetics, and glass and metal containers. As a world leader in track and trace solutions for pharmaceutical products, the Group provides major global manufacturers (over 50% of the top 20 multinationals) and numerous government authorities with solutions, monitoring their supply chains and validating product authenticity. Listed since April 2019 on the Italian Stock Exchange in the Alternative Investment Market (AIM) segment and from 14 May 2021 in the STAR segment of Euronext; furthermore, from July 2022 included in the Euronext Tech Leaders index, dedicated to leading tech companies with high growth potential. In 2022, Antares Vision Group recorded a turnover of €223.5 million. The Group operates in 60 countries, employs more than 1,100 people, and has a consolidated network of over 40 international partners. To learn more, please visit www.antaresvision.com and www.antaresvisiongroup.com.

ABOUT SPHERITY

Spherity is a German software provider bringing secure and decentralized identity management solutions to enterprises, machines, products, data and even algorithms. Spherity provides the enabling technology to digitalize and automate compliance processes in highly regulated technical sectors. Spherity’s products empower cybersecurity, efficiency and data interoperability among digital value chains. Spherity is certified according to the information security standard ISO 27001.

Antares Vision Group, Through rfxcel, Begins Partnership with Renown Health Network for DSCSA-Compliant Pharmaceutical Tracking

Posted on by rfxadmin

rfxcel, part of Antares Vision Group, will implement DSCSA compliance solutions to help ensure pharmacies across the northern Nevada healthcare network comply with the regulations.

Reno, Nevada, March 8, 2023 — Antares Vision Group (EXM, AV:IM), a leading provider of track and trace and quality control systems, today announced that rfxcel, which is part of the Group, has begun a partnership with Renown Health Foundation to implement compliance software so the network can track and trace pharmaceuticals in compliance with the Drug Supply Chain Security Act (DSCSA).

With rfxcel’s DSCSA compliance solutions, Renown Health’s medical groups and pharmacies will achieve real-time electronic tracing of drug products at the package level to identify and trace prescription drugs as they are distributed throughout the health system. This will enhance Renown’s ability to help protect patients from exposure to drugs that may be counterfeit, stolen, contaminated, or otherwise harmful.

“Reno has been our home since 2018 and many of our employees live and work in the northern Nevada region,” said rfxcel CEO Glenn Abood. “Renown is one of the leading not-for-profit healthcare organizations here and is the perfect partner to team with to give back to our community. We are excited about the opportunity to work with them and to help improve the health and well-being of our friends and neighbors.”

“Ensuring our patient’s medications are safe and legitimate is of the upmost importance to us,” said Renown’s Vice President of Pharmacy Services Adam Porath. “When members of our community get involved in our work, it brings us all closer together. We are thankful that Antares Vision Group and rfxcel are partnering with us on our healing mission. They are making it possible for us to keep our patients safe, comply with the demanding DSCSA requirements, and respond quickly to changing supply chain requirements.”

For further information, write us at news@rfxcel.com.

 

ABOUT ANTARES VISION GROUP

Antares Vision Group is an outstanding technology partner in digitalization and innovation for companies and institutions, guaranteeing the safety of products and people, business competitiveness, and environmental protection. The Group provides a unique and comprehensive ecosystem of technologies to guarantee product quality (inspection systems and equipment) and end-to-end product traceability (from raw materials to production, from distribution to the consumer) through integrated data management, applying artificial intelligence and blockchain technology. Antares Vision Group is active in life science (pharmaceutical, biomedical devices and hospitals) and Fast-Moving Consumer Goods (FMCG), including food, beverage, cosmetics, and glass and metal containers. As a world leader in track and trace solutions for pharmaceutical products, the Group provides major global manufacturers (over 50% of the top 20 multinationals) and numerous government authorities with solutions, monitoring their supply chains and validating product authenticity. Listed since April 2019 on the Italian Stock Exchange in the Alternative Investment Market (AIM) segment and from 14 May 2021 in the STAR segment of the Mercato Telematico Azionario (MTA), Antares Vision Group recorded a turnover of €179 million in 2021, operates in 60 countries, employs more than 1,000 people, and has a consolidated network of over 40 international partners. To learn more, please visit www.antaresvision.com and www.antaresvisiongroup.com.

ABOUT RENOWN HEALTH

Renown Health is Nevada’s largest, not-for-profit integrated healthcare network serving Nevada, Lake Tahoe, and northeast California. With a diverse workforce of more than 9,000 employees, Renown has fostered a longstanding culture of excellence, determination, and innovation. The organization comprises a trauma center, two acute care hospitals, a children’s hospital, a rehabilitation hospital, a medical group and urgent care network, and the locally owned not-for-profit insurance company, Hometown Health. Renown is currently enrolling participants in a community-based genetic population health study, the Healthy Nevada Project®.

For a Leading Berry Producer, Antares Vision Group Digitalizes Billions of Products for Tight Supply Chain Oversight and Direct Consumer Connections

Posted on by rfxadmin

The Group’s Supply Chain Transparency solution serializes packages in the field, enabling the use of unit-level data to help ensure customers are satisfied with product quality.

Travagliato (Brescia), January 17, 2023 – Antares Vision Group (EXM, AV:IM), an Italian multinational and a leading provider of track and trace and quality control systems that ensures the transparency of products and supply chains through integrated data management, has successfully piloted a Supply Chain Transparency solution for a prominent berry company. The project entails the digitalization of over 1.5 billion products, empowering the berry producer to protect, support, and communicate with its customers.

Powered by technology from rfxcel, which is part of Antares Vision Group, the Supply Chain Transparency solution package enables data concerning harvested berries to be collected and integrated into a platform that fully controls product safety and quality.

Using Antares Vision Group’s advanced serialization and mobile traceability technologies, the producer scans each individual clamshell to associate berry type, farm, and growing conditions, giving each package a unique digital identity with detailed product information. Consumers can scan an on-package QR Code to take a survey, giving the producer valuable insight into its customers’ impressions of specific berries grown at specific locations. This allows the company to focus on the types of berries consumers like best, and to ensure product quality is maintained at high standards from field to end user.

Glenn Abood, CEO of rfxcel, said the project showcases the technology’s impact and scalability. “We’re really expanding boundaries with this project,” he said. “Our coordination with the berry producer has been greatly rewarding; together, we’ve designed a system that reliably manages billions of products in the first and last mile of the supply chain. It performs these tasks day in and day out, with sub-second scanning times and exacting accuracy.”

Abood added that Antares Vision Group and the producer had discussed other applications for the wide-scale serialization of products, such as using digitalized unit-level data for consumer engagement activities and risk-mitigation strategies.

Abood continued: “Our serialization technologies are opening up entirely new avenues for brand value and benefits, connecting safety, quality, efficiency, and trust. The brand owners have actionable and granular information about consumer preferences, opening new dialogue channels and highly targeted customer interactions. Recall management is another benefit: It’s not necessary to recall every package, only a single clamshell. These advantages are available only with serialized products, which unlock opportunities with the power of unit-level data.”

For further information

Herb Wong, Senior Vice President, Product and Strategy: +1 925 791 3235 / hwong@rfxcel.com

Alessandro Baj Badino, Head of Investor Relations: +39 030 72 83 500 / investors@antaresvision.com

Davide Antonioli, Investor Relator: +39 030 7283500 / investors@antaresvision.com

Federica Menichino, Axelcomm (Press Contact): +39 3496976982 / federica.menichino@axel-comm.it

 

ABOUT ANTARES VISION GROUP

Antares Vision Group is an outstanding technology partner in digitalization and innovation for companies and institutions, guaranteeing the safety of products and people, business competitiveness, and environmental protection. The Group provides a unique and comprehensive ecosystem of technologies to guarantee product quality (inspection systems and equipment) and end-to-end product traceability (from raw materials to production, from distribution to the consumer) through integrated data management, applying artificial intelligence and blockchain technology. Antares Vision Group is active in life science (pharmaceutical, biomedical devices and hospitals) and Fast-Moving Consumer Goods (FMCG), including food, beverage, cosmetics, and glass and metal containers. As a world leader in track and trace solutions for pharmaceutical products, the Group provides major global manufacturers (over 50% of the top 20 multinationals) and numerous government authorities with solutions, monitoring their supply chains and validating product authenticity. Listed since April 2019 on the Italian Stock Exchange in the Alternative Investment Market (AIM) segment and from 14 May 2021 in the STAR segment of the Mercato Telematico Azionario (MTA), Antares Vision Group recorded a turnover of €179 million in 2021, operates in 60 countries, employs more than 1,000 people, and has a consolidated network of over 40 international partners. To learn more, please visit www.antaresvision.com and www.antaresvisiongroup.com.

rfxcel is part of
Rfxcel Logo

© 2023 ANTARES VISION S.p.A. - Via Del Ferro, 16 - 25039 Travagliato - Brescia - ITALY Tel.: +39-030-7283500 / Fax.: +39-030-5109958 / info@antaresvision.com - C/F PIVA: 02890871201 Registro Imprese di Brescia C.C.I.A.A. di Brescia (REA) n. 523277